Pediatrics
News from the FDA/CDC
FDA OKs empagliflozin for children with type 2 diabetes
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.
Latest News
Once-weekly growth hormone somapacitan approved for children
The European Medicine Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the product for replacement...
Conference Coverage
Half of deaths from homozygous FH occur before age 32 years
“We should do something to prolong the lives of those people,” because the current results are “terrifying.”
Conference Coverage
Half of teens drop below obesity cutoff with semaglutide
The semaglutide findings are “historically unprecedented with treatments other than bariatric surgery.”
Latest News
Contact allergens lurk in diabetes devices
Some reports suggest that at any given time, skin complications may affect as many as one quarter to one half of patients who use diabetes devices...
Feature
Should youth with type 1 diabetes use closed-loop systems?
Several studies show the adolescents who were disengaged from their diabetes management do better on closed-loop systems.
Opinion
LGBTQ+ Youth Consult Questions remain over use of sex hormone therapy
The use of GnRH agonists in transgender adolescents remains controversial because of the potential long-term effects on bone mineral density.
Latest News
Study offers dozens of reasons to cut sugar
The result is a list that cites the world’s most common health problems like heart disease, diabetes, obesity, high blood pressure, heart attack,...
Opinion
Time to rebuild
Latest News
Infant and maternal weight gain together amplify obesity risk
A new study finds monitoring infants for rapid weight gain is particularly important when mothers have elevated prepregnancy weight.
From the Journals
New AHA statement on pediatric primary hypertension issued
“Primary hypertension is now recognized as the most common type of hypertension in childhood.”